Oliger Christy J.
SEC insider (Form 3/4/5 filer). CIK 0001822092. Director at Zenas BioPharma, Inc. (ZBIO) and 6 other issuers. 14 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in WALTHAM, MA.
Companies Oliger Christy J. has filed insider reports for
- Zenas BioPharma, Inc. (ZBIO): Director
- Bicara Therapeutics Inc. (BCAX): Director
- Nuvalent, Inc. (NUVL): Director
- Vera Therapeutics, Inc. (VERA): Director
- Karyopharm Therapeutics Inc. (KPTI): Director
- Replimune Group, Inc. (REPL): Director
- LAVA Therapeutics NV (LVTX): Director
Oliger Christy J.
CIK: 0001822092
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Sep 1, 2026ZBIO
Zenas BioPharma, Inc.
AwardDirectStock Option (Right to Buy)
37K shares- - Jul 28, 2026BCAX
Bicara Therapeutics Inc.
AwardDirectStock Option (Right to Buy)
39K shares- - Jul 15, 2026NUVL
Nuvalent, Inc.
Tender OfferDirect1.3K shares at avg. $124.00$164K - Jul 15, 2026NUVL
Nuvalent, Inc.
DispositionDirect6.1K shares- - Jun 16, 2026NUVL
Nuvalent, Inc.
AwardDirect3.4K shares- - May 21, 2026VERA
Vera Therapeutics, Inc.
AwardDirectStock Option (right to buy)
17.1K shares- - May 21, 2026KPTI
Karyopharm Therapeutics Inc.
AwardDirect15.5K shares- - Apr 1, 2026REPL
Replimune Group, Inc.
AwardDirectStock Option (right to buy)
44.5K shares- - Nov 13, 2025LVTX
LAVA Therapeutics NV
DispositionDirectShare Options (Right to Buy)
33.4K shares- - Jun 18, 2025NUVL
Nuvalent, Inc.
AwardDirect4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 |  ZBIO Zenas BioPharma, Inc. | Award Stock Option (Right to Buy) | 37,000 | - | - | Direct |
| Jul 28, 2026 |  BCAX Bicara Therapeutics Inc. | Award Stock Option (Right to Buy) | 38,950 | - | - | Direct |
| Jul 15, 2026 |  NUVL Nuvalent, Inc. | Tender Offer | 1,324 | $124.00 | $164,176 | Direct |
| Jul 15, 2026 | NUVL Nuvalent, Inc. | Disposition | 6,091 | - | $0 | Direct |
| Jun 16, 2026 | NUVL Nuvalent, Inc. | Award | 3,444 | - | $0 | Direct |
| May 21, 2026 |  VERA Vera Therapeutics, Inc. | Award Stock Option (right to buy) | 17,084 | - | - | Direct |
| May 21, 2026 |  KPTI Karyopharm Therapeutics Inc. | Award | 15,508 | - | $0 | Direct |
| Apr 1, 2026 |  REPL Replimune Group, Inc. | Award Stock Option (right to buy) | 44,500 | - | - | Direct |
| Nov 13, 2025 |  LVTX LAVA Therapeutics NV | Disposition Share Options (Right to Buy) | 33,390 | - | - | Direct |
| Jun 18, 2025 | NUVL Nuvalent, Inc. | Award | 3,971 | - | - | Direct |
1-10 of 14 transactions